ClinicalTrials.Veeva

Menu

Plasma Level of Mitochondrial DNA in Patients With ARDS and Its Clinical Significance

C

Chun Pan

Status

Unknown

Conditions

Evaluate the Correlation Between the Level of Mitochondrial DNA in Plasma and the Prognosis of the Patients With ARDS.

Treatments

Other: taking peripheral blood

Study type

Observational

Funder types

Other

Identifiers

NCT02883231
ARDS mtDNA

Details and patient eligibility

About

To observe the changes of plasma mitochondrial DNA (mtDNA) levels in patients with ARDS, and to explore its clinical significance.

Full description

60 patients who diagnosed as ARDS were included in this study.Then keep blood samples from these patients in the first day、the third day and the sveventh day,detect the mitochotndrial DNA level in plasma by real-time quantitative PCR. Recored Severity of illness and survival status of every patient within 28 days.Objective to evaluate the correlation between the level of mitochondrial DNA in plasma and the prognosis of the patients.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients admitted to ICU diagnosed of ARDS (Berlin criteria),
  2. Patients age between 18 years old and 80 years.

Exclusion criteria

  1. Pregnant women,
  2. Patients with malignant tumor,
  3. Immunosuppression or immunocompromised patients.

Trial contacts and locations

1

Loading...

Central trial contact

Haibo Qiu, Dr; Lili Huang, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems